Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
12 pending office actions • 9 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Soonchunhyang University Industry Academy Cooperation Foundation currently manages 12 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 12 pending office actions are distributed across 12 distinct examiners and 9 distinct art units. The 12 distinct examiners indicate that each pending matter is being reviewed by a different individual. The 9 distinct art units suggest that the portfolio is spread across several administrative groups within the patent office.
UHLENHAKE, JASON S is identified as the busiest examiner for this portfolio. This examiner is responsible for 1 busiest_examiner_pending action. The 1 busiest_examiner_pending action is one of the 12 pending office actions currently active. UHLENHAKE, JASON S and the other 12 distinct examiners handle the workload within the Biotechnology & Pharmaceuticals area. The 9 distinct art units provide the technical context for these applications.
The 12 pending office actions require coordination with 12 distinct examiners. UHLENHAKE, JASON S holds 1 busiest_examiner_pending action, showing a broad distribution of cases across the examiners. Practitioners should address the requirements of the 9 distinct art units to advance the portfolio. The Biotechnology & Pharmaceuticals area defines the technical scope for all 12 pending office actions.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (25%) |
| §103 only | 2 (17%) |
| Multi-statute (no §101) | 7 (58%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| UHLENHAKE, JASON S | 1 | 87.4% | -2.4% |
| NEAGU, IRINA | 1 | 46.7% | +57.2% |
| YOON, CHANEL J | 1 | 55.5% | +39.3% |
| FIDLER, SHELBY LEE | 1 | 79.1% | +14.3% |
| SCHLOOP, ALLISON ELIZABETH | 1 | 63.3% | +47.6% |
| CHUNDURU, SURYAPRABHA | 1 | 53.3% | +17.2% |
| GOLLAMUDI, NEERAJA | 1 | 72.6% | +40.0% |
| KOHUTKA, BROOKE NICOLE | 1 | 37.5% | +92.3% |
| BAUSCH, SARAE L | 1 | 29.7% | +45.0% |
| PIERRE LOUIS, ANDRE | 1 | 68.2% | +15.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17744162 | USE OF SILDENAFIL AND ROCK INHIBITORS FOR TREATING STROKE OR SEQUELAE FOLLOWING STROKE | SCHMITT, MICHAEL J | 30d |
| 18039563 | PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME | BAUSCH, SARAE L | 33d |
| 19180156 | INKJET HEAD MONITORING SYSTEM AND METHOD | UHLENHAKE, JASON S | — |
| 19032593 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISORDERS COMPRISING AURANOFIN AS AN ACTIVE INGREDIENT | NEAGU, IRINA | — |
| 18833553 | MICROBIOME COLLECTION DEVICE | YOON, CHANEL J | — |
| 18584279 | METHOD FOR DETECTING TARGET NUCLEIC ACIDS USING PLASMONIC IMMUNOMAGNETIC NANOPARTICLES | SCHLOOP, ALLISON ELIZABETH | — |
| 18583776 | RAPID TARGET GENE DETECTION METHOD USING PLASMONIC PHOTOTHERMAL REACTION | CHUNDURU, SURYAPRABHA | — |
| 18284017 | SLEEVE GASTRECTOMY AID DEVICE | KOHUTKA, BROOKE NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18039563 | PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME | BAUSCH, SARAE L | 33d |
| 18666247 | INKJET PRINTING SYSTEM | FIDLER, SHELBY LEE | 71d |
| 19032593 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISORDERS COMPRISING AURANOFIN AS AN ACTIVE INGREDIENT | NEAGU, IRINA | — |
| 18833553 | MICROBIOME COLLECTION DEVICE | YOON, CHANEL J | — |
| 18584279 | METHOD FOR DETECTING TARGET NUCLEIC ACIDS USING PLASMONIC IMMUNOMAGNETIC NANOPARTICLES | SCHLOOP, ALLISON ELIZABETH | — |
| 18583776 | RAPID TARGET GENE DETECTION METHOD USING PLASMONIC PHOTOTHERMAL REACTION | CHUNDURU, SURYAPRABHA | — |
| 18270012 | SLEEVE GASTRECTOMY AID DEVICE | GOLLAMUDI, NEERAJA | — |
| 18284017 | SLEEVE GASTRECTOMY AID DEVICE | KOHUTKA, BROOKE NICOLE | — |
| Art Unit | Apps |
|---|---|
| 2853 | 2 |
| 1629 | 2 |
| 3791 | 2 |
| 1683 | 1 |
| 1672 | 1 |
| 3783 | 1 |
| 1699 | 1 |
| 2187 | 1 |
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19180156 | INKJET HEAD MONITORING SYSTEM AND METHOD | UHLENHAKE, JASON S | 2853 | §102§103 | Non-Final OA | — | Pending | Apr 16, 2025 |
| 19032593 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISORDERS COMPRISING AURANOFIN AS AN ACTIVE INGREDIENT | NEAGU, IRINA | 1629 | §102§103 | Non-Final OA | — | Pending | Jan 21, 2025 |
| 18833553 | MICROBIOME COLLECTION DEVICE | YOON, CHANEL J | 3791 | §102§112 | Final Rejection | — | Pending | Jul 26, 2024 |
| 18666247 | INKJET PRINTING SYSTEM | FIDLER, SHELBY LEE | 2853 | §103 | Final Rejection | 71d | Pending | May 16, 2024 |
| 18584279 | METHOD FOR DETECTING TARGET NUCLEIC ACIDS USING PLASMONIC IMMUNOMAGNETIC NANOPARTICLES | SCHLOOP, ALLISON ELIZABETH | 1683 | §103§112 | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18583776 | RAPID TARGET GENE DETECTION METHOD USING PLASMONIC PHOTOTHERMAL REACTION | CHUNDURU, SURYAPRABHA | 1672 | §103§112 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18270012 | SLEEVE GASTRECTOMY AID DEVICE | GOLLAMUDI, NEERAJA | 3783 | §103 | Final Rejection | — | Pending | Jan 22, 2024 |
| 18284017 | SLEEVE GASTRECTOMY AID DEVICE | KOHUTKA, BROOKE NICOLE | 3791 | §102§103§112 | Final Rejection | — | Pending | Sep 25, 2023 |
| 18039563 | PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME | BAUSCH, SARAE L | 1699 | §101§102§103§112 | Non-Final OA | 33d | Pending | May 31, 2023 |
| 18201809 | FREE MOTION HEADFORM IMPACT PERFORMANCE PREDICTION DEVICE AND A METHOD USING ARTIFICIAL INTELLIGENCE | PIERRE LOUIS, ANDRE | 2187 | §101§103 | Non-Final OA | — | Pending | May 25, 2023 |
| 17907432 | COMPOSITION USING URINE SAMPLE FOR DIAGNOSIS OF KIDNEY DISEASE | EVANS, CHRISTOPHER RYAN | 1677 | §101§103 | Non-Final OA | — | Pending | Sep 27, 2022 |
| 17744162 | USE OF SILDENAFIL AND ROCK INHIBITORS FOR TREATING STROKE OR SEQUELAE FOLLOWING STROKE | SCHMITT, MICHAEL J | 1629 | §103§112 | Final Rejection | 30d | Pending | May 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSoonchunhyang University Industry Academy Cooperation Foundation has 12 pending office actions as of October 2026, spread across 9 art units and 12 examiners.
Jason S Uhlenhake has the most, with 1 of Soonchunhyang University Industry Academy Cooperation Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
